Gemcitabine Hcl Market

Gemcitabine HCL Market (Type: Branded and Generic; Application: Pancreatic Cancer, Breast Cancer, Ovarian Cancer, Non-small-cell Lung Carcinoma (NSCLC), and Others; End-user: Hospitals, Cancer Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • Rep Id : TMRGL67622
  • Published On : Jun 2019
  • No. of Pages : 210
  • Category : Pharmaceutical

1. Global Gemcitabine HCL Market – Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology
    2.1. Gemcitabine HCL Market Definition
    2.2. Gemcitabine HCL Market Taxonomy

3. Executive Summary : Global Gemcitabine HCL Market
    3.1. Market Overview
    3.2. Introduction
    3.3. Type Definition
        3.3.1. Industry Evolution / Developments
    3.4. Overview
    3.5. Market Dynamics
        3.5.1. Drivers
        3.5.2. Restraints
        3.5.3. Opportunities
    3.6. Global Gemcitabine HCL Market Analysis and Forecast
        3.6.1. Market Revenue Projections (US$ Mn)
    3.7. Porter’s Five Force Analysis

4. Key Insights
    4.1. Disease Prevalence & Incidence Rate globally with key countries
    4.2. Regulatory Scenario by Region/globally
    4.3. Pipeline Analysis
    4.4. Key Mergers & Acquisitions
    4.5. Pricing Analysis of Finished products
    4.6. Overview of Manufacturers
    4.7. Consumption of Gemcitabine HCL(Volume) per Region (2018)
    4.8. Prices by Key Manufacturers(US$/kg)

5. Global Gemcitabine HCL Market Analysis and Forecast, By Type 
    5.1. Introduction
        5.1.1. Introduction & Definition By Type 
        5.1.2. Key Findings / Developments By Type 
    5.2. Market Size (US$ Mn) Forecast By Type 
        5.2.1. Branded 
        5.2.2. Generic 
    5.3. Market Attractiveness Analysis By Type 

6. Global Gemcitabine HCL Market Analysis and Forecast, By Application 
    6.1. Introduction
        6.1.1. Introduction & Definition By Application 
        6.1.2. Key Findings / Developments By Application 
    6.2. Market Size (US$ Mn) Forecast By Application 
        6.2.1. Pancreatic Cancer
        6.2.2. Breast Cancer
        6.2.3. Ovarian Cancer
        6.2.4. Non-small-cell Lung Carcinoma (NSCLC)
        6.2.5. Other

7. Global Gemcitabine HCL Market Analysis and Forecast, By End User 
    7.1. Introduction
        7.1.1. Introduction & Definition By End User 
        7.1.2. Key Findings / Developments By End User 
    7.2. Market Size (US$ Mn) Forecast By End User 
        7.2.1. Hospitals 
        7.2.2. Cancer Centers 
        7.2.3. Others  

8. Global Gemcitabine HCL Market Analysis and Forecast, By Region/sub-Region
    8.1. Introduction
        8.1.1. Introduction & Definition 
        8.1.2. Key Findings / Developments 
    8.2. Market Size (US$ Mn) Forecast By Region/Sub-Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific 
        8.2.4. Latin America
        8.2.5. Middle East and Africa (MEA)
    8.3. Market Attractiveness Analysis By Region/Sub-Region

9. North America Gemcitabine HCL Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Introduction & Definition 
        9.1.2. Key Findings / Developments 
    9.2. Market Size (US$ Mn) Forecast By Country
        9.2.1. U.S.
        9.2.2. Canada
    9.3. Market Size (US$ Mn) Forecast By Type 
        9.3.1. Branded 
        9.3.2. Generic 
    9.4. Market Size (US$ Mn) Forecast By Application 
        9.4.1. Pancreatic Cancer
        9.4.2. Breast Cancer
        9.4.3. Ovarian Cancer
        9.4.4. Non-small-cell Lung Carcinoma (NSCLC)
        9.4.5. Other
    9.5. Market Size (US$ Mn) Forecast By End User 
        9.5.1. Hospitals
        9.5.2. Cancer Centers 
        9.5.3. Others  
    9.6. Market Attractiveness Analysis
        9.6.1. By Country
        9.6.2. By Type 
        9.6.3. By Application 
        9.6.4. By End User 

10. Europe Gemcitabine HCL Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Introduction & Definition 
        10.1.2. Key Findings / Developments 
    10.2. Market Size (US$ Mn) and Forecast By Country /Sub-Region
        10.2.1. Germany
        10.2.2. France
        10.2.3. Italy
        10.2.4. Spain
        10.2.5. U.K.
        10.2.6. Rest of  Europe
    10.3. Market Size (US$ Mn) Forecast By Type 
        10.3.1. Branded 
        10.3.2. Generic 
    10.4. Market Size (US$ Mn) Forecast By Application 
        10.4.1. Pancreatic Cancer
        10.4.2. Breast Cancer
        10.4.3. Ovarian Cancer
        10.4.4. Non-small-cell Lung Carcinoma (NSCLC)
        10.4.5. Other
    10.5. Market Size (US$ Mn) Forecast By End User 
        10.5.1. Hospitals
        10.5.2. Cancer Centers 
        10.5.3. Others  
    10.6. Market Attractiveness Analysis
        10.6.1. By Country
        10.6.2. By Type 
        10.6.3. By Application 
        10.6.4. By End User 

11. Asia Pacific  Gemcitabine HCL Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Introduction & Definition 
        11.1.2. Key Findings / Developments 
    11.2. Market Size (US$ Mn) and Forecast By Country / Region
        11.2.1. China
        11.2.2. India
        11.2.3. Japan
        11.2.4. Australia and New Zealand
        11.2.5. Rest of Asia-Pacific
    11.3. Market Size (US$ Mn) Forecast By Type 
        11.3.1. Branded 
        11.3.2. Generic 
    11.4. Market Size (US$ Mn) Forecast By Application 
        11.4.1. Pancreatic Cancer
        11.4.2. Breast Cancer
        11.4.3. Ovarian Cancer
        11.4.4. Non-small-cell Lung Carcinoma (NSCLC)
        11.4.5. Other
    11.5. Market Size (US$ Mn) Forecast By End User 
        11.5.1.  Hospitals
        11.5.2. Cancer Centers 
        11.5.3. Others  
    11.6. Market Attractiveness Analysis
        11.6.1. By Country
        11.6.2. By Type 
        11.6.3. By Application 
        11.6.4. By End User 

12. Latin America Gemcitabine HCL Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Introduction & Definition 
        12.1.2. Key Findings / Developments 
    12.2. Market Size (US$ Mn) and Forecast By Country
        12.2.1. Brazil
        12.2.2. Mexico
        12.2.3. Rest of Latin America
    12.3. Market Size (US$ Mn) Forecast By Type 
        12.3.1. Branded 
        12.3.2. Generic 
    12.4. Market Size (US$ Mn) Forecast By Application 
        12.4.1. Pancreatic Cancer
        12.4.2. Breast Cancer
        12.4.3. Ovarian Cancer
        12.4.4. Non-small-cell Lung Carcinoma (NSCLC)
        12.4.5. Other
    12.5. Market Size (US$ Mn) Forecast By End User 
        12.5.1. Hospitals
        12.5.2. Cancer Centers 
        12.5.3. Others  
    12.6. Market Attractiveness Analysis
        12.6.1. By Country
        12.6.2. By Type 
        12.6.3. By Application 
        12.6.4. By End User 

13. MEA Gemcitabine HCL Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Introduction & Definition 
        13.1.2. Key Findings / Developments 
        13.1.3. Key Regulations
    13.2. Market Size (US$ Mn) Forecast By Country
        13.2.1. GCC Countries
        13.2.2. South Africa
        13.2.3. Rest of MEA
    13.3. Market Size (US$ Mn) Forecast By Type 
        13.3.1. Branded 
        13.3.2. Generic 
    13.4. Market Size (US$ Mn) Forecast By Application 
        13.4.1. Pancreatic Cancer
        13.4.2. Breast Cancer
        13.4.3. Ovarian Cancer
        13.4.4. Non-small-cell Lung Carcinoma (NSCLC)
        13.4.5. Other
    13.5. Market Size (US$ Mn) Forecast By End User 
        13.5.1. Hospitals
        13.5.2. Cancer Centers 
        13.5.3. Others  
    13.6. Market Attractiveness Analysis
        13.6.1. By Country
        13.6.2. By Type 
        13.6.3. By Application 
        13.6.4. By End User 

14. Competition Landscape
    14.1. Market Player - Competition Matrix 
    14.2. Market Share Analysis, by Company
        14.2.1. Eli Lilly and Company
        14.2.2. Teva Pharmaceutical Industries Ltd.
        14.2.3. Accord-UK Ltd.
        14.2.4. Pfizer, Inc.
        14.2.5. Mylan N.V.
        14.2.6. Sun Pharmaceutical Industries Ltd.
        14.2.7. Fresenius Kabi AG
        14.2.8. Dr. Reddy’s Laboratories Ltd.
        14.2.9. Ingenus Pharmaceuticals

List of Tables

Table 1: FDA Approved Drug Products 
Table 2: Pancreatic Cancer Promising Drugs in Clinical Development 
Table 3: Global Generic Products Sector Condition Overview
Table 4: Pricing Analysis of Finished Products
Table 5: USFDA Approved Gemcitabine HCL Manufacturers
Table 6: Europe Gemcitabine HCL Manufacturers
Table 7: India Gemcitabine HCL Manufacturers
Table 8: China Gemcitabine HCL Manufacturers
Table 9: Global Gemcitabine HCL Value (US$ Mn) Forecast, by Type, 2017–2027
Table 10: Global Gemcitabine HCL Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 11: Global Gemcitabine HCL Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 12: Global Gemcitabine HCL Value (US$ Mn) Forecast, by Region, 2017–2027
Table 13: North America Gemcitabine HCL Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 14: North America Gemcitabine HCL Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 15: North America Gemcitabine HCL Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 16: North America Gemcitabine HCL Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 17: Europe Gemcitabine HCL Market Value (US$ Mn) Forecast, by Country/Region, 2017–2027
Table 18: Europe Gemcitabine HCL Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 19: Europe Gemcitabine HCL Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 20: Europe Gemcitabine HCL Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 21: Asia Pacific Gemcitabine HCL Market Value (US$ Mn) Forecast, by Country/Region, 2017–2027
Table 22: Asia Pacific Gemcitabine HCL Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 23: Asia Pacific Gemcitabine HCL Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 24: Asia Pacific Gemcitabine HCL Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 25: Latin America Gemcitabine HCL Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Latin America Gemcitabine HCL Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 27: Latin America Gemcitabine HCL Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 28: Latin America Gemcitabine HCL Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 29: Middle East & Africa Gemcitabine HCL Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 30: Middle East & Africa Gemcitabine HCL Market Value (US$ Mn) Forecast, by Type , 2017–2027
Table 31: Middle East & Africa Gemcitabine HCL Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 32: Middle East & Africa Gemcitabine HCL Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global Gemcitabine HCL Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 02: Global Gemcitabine HCL Value Share, by Type, 2018
Figure 03: Global Gemcitabine HCL Value Share, by Application, 2018
Figure 04: Global Market Value Share, by End-user, 2018
Figure 05: Global Gemcitabine HCL Value Share, by Region, 2018
Figure 06: Global Gemcitabine HCL Value Share Analysis, by Type, 2019 and 2027
Figure 07: Global Gemcitabine HCL Market Attractiveness Analysis, by Type, 2019 and 2027
Figure 08: Global Gemcitabine HCL Revenue (US$ Mn) and Y-o-Y Growth (%), by Branded, 2017–2027
Figure 09: Global Gemcitabine HCL Revenue (US$ Mn) and Y-o-Y Growth (%), by Generic, 2017–2027
 Figure 10: Global Gemcitabine HCL Market Value Share (%), by Application, 2019 and 2027
Figure 11: Global Gemcitabine HCL Market Attractiveness, by Application, 2019–2027
Figure 12: Global Gemcitabine HCL Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Pancreatic Cancer, 2017–2027
Figure 13: Global Gemcitabine HCL Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Breast Cancer, 2017–2027
Figure 14: Global Gemcitabine HCL Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ovarian Cancer , 2017–2027
Figure 15: Global Gemcitabine HCL Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Non-small-cell Lung Carcinoma (NSCLC) , 2017–2027
Figure 16: Global Gemcitabine HCL Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027
Figure 17: Global Gemcitabine HCL Market Value Share Analysis, by End-user, 2019 and 2027
Figure 18: Global Gemcitabine HCL Market Attractiveness Analysis, by End-user, 2019–2027
Figure 19: Global Gemcitabine HCL Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2027
Figure 20: Global Gemcitabine HCL Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cancer Centers, 2017–2027
Figure 21: Global Gemcitabine HCL Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 22: Global Gemcitabine HCL Market Value Share, by Region, 2019 and 2027
Figure 23 : Global Gemcitabine HCL Market Attractiveness, by Region, 2019–2027
Figure 24: North America Gemcitabine HCL Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 25: North America Gemcitabine HCL Market Value Share, by Country, 2019–2027
Figure 26: North America Gemcitabine HCL Market Attractiveness, by Country, 2019–2027
Figure 27: North America Gemcitabine HCL Market Value Share Analysis, by Type, 2019 and 2027
Figure 28: North America Gemcitabine HCL Market Attractiveness Analysis, by Type, 2019–2027
Figure 29: North America Gemcitabine HCL Market Value Share Analysis, by Application, 2019 and 2027
Figure 30: North America Gemcitabine HCL Market Attractiveness Analysis, by Application, 2019–2027
Figure 31: North America Gemcitabine HCL Market Value Share Analysis, by End-user, 2019 and 2027
Figure 32: North America Gemcitabine HCL Market Attractiveness Analysis, by End-user, 2019–2027
Figure 33: Europe Gemcitabine HCL Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 34: Europe Gemcitabine HCL Market Value Share, by Country/Sub-region, 2019–2027
Figure 35: Europe Gemcitabine HCL Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 36: Europe Gemcitabine HCL Market Value Share Analysis, by Type, 2019 and 2027
Figure 37: Europe Gemcitabine HCL Market Attractiveness Analysis, by Type, 2019–2027
Figure 38: Europe Gemcitabine HCL Market Value Share Analysis, by Application, 2019 and 2027
Figure 39: Europe Gemcitabine HCL Market Attractiveness Analysis, by Application, 2019–2027
Figure 40: Europe Gemcitabine HCL Market Value Share Analysis, by End-user, 2019 and 2027
Figure 41: Europe Gemcitabine HCL Market Attractiveness Analysis, by End-user, 2019–2027
Figure 42: Asia Pacific Gemcitabine HCL Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 43: Asia Pacific Gemcitabine HCL Market Value Share, by Country/Sub-region, 2019–2027
Figure 44: Asia Pacific Gemcitabine HCL Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 45: Asia Pacific Gemcitabine HCL Market Value Share Analysis, by Type, 2019 and 2027
Figure 46: Asia Pacific Gemcitabine HCL Market Attractiveness Analysis, by Type, 2019–2027
Figure 47: Asia Pacific Gemcitabine HCL Market Value Share Analysis, by Application, 2019 and 2027
Figure 48: Asia Pacific Gemcitabine HCL Market Attractiveness Analysis, by Application, 2019–2027
Figure 49 : Asia Pacific Gemcitabine HCL Market Value Share Analysis, by End-user, 2019 and 2027
Figure 50 : Asia Pacific Gemcitabine HCL Market Attractiveness Analysis, by End-user, 2019–2027
Figure 51: Latin America Gemcitabine HCL Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 52: Latin America Gemcitabine HCL Market Value Share, by Country/Sub-region, 2019–2027
Figure 53: Latin America Gemcitabine HCL Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 54: Latin America Gemcitabine HCL Market Value Share Analysis, by Type, 2019 and 2027
Figure 55: Latin America Gemcitabine HCL Market Attractiveness Analysis, by Type, 2019–2027
Figure 56: Latin America Gemcitabine HCL Market Value Share Analysis, by Application, 2019 and 2027
Figure 57: Latin America Gemcitabine HCL Market Attractiveness Analysis, by Application, 2019–2027
Figure 58: Latin America Gemcitabine HCL Market Value Share Analysis, by End-user, 2019 and 2027
Figure 59: Latin America Gemcitabine HCL Market Attractiveness Analysis, by End-user, 2019–2027
Figure 60: Middle East & Africa Gemcitabine HCL Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 61: Middle East & Africa Gemcitabine HCL Market Value Share, by Country/Sub-region, 2019–2027
Figure 62: Middle East & Africa Gemcitabine HCL Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 63: Middle East & Africa Gemcitabine HCL Market Value Share Analysis, by Type, 2019 and 2027
Figure 64: Middle East & Africa Gemcitabine HCL Market Attractiveness Analysis, by Type, 2019–2027
Figure 65: Middle East & Africa Gemcitabine HCL Market Value Share Analysis, by Application, 2019 and 2027
Figure 66: Middle East & Africa Gemcitabine HCL Market Attractiveness Analysis, by Application, 2019–2027
Figure 67: Middle East & Africa Gemcitabine HCL Market Value Share Analysis, by End-user, 2019 and 2027
Figure 68: Middle East & Africa Gemcitabine HCL Market Attractiveness Analysis, by End-user, 2019–2027
Figure 69: Top Players operating in Market Space

.